NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 22 of 24
Hypertension and Sleep Disordered Breathing in Pediatrics
NCT00990899
Trial of Educational Outcomes of WISE-MD
NCT01322230
Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance
NCT01180361
Study of Wound Packing After Superficial Skin Abscess Drainage
NCT00746109
A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function
NCT01218334
Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
NCT00708916
Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer
NCT00933088
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
NCT00848783
Counseling Older Adults to Control Hypertension
NCT01180673
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
NCT00846612
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
NCT00895063
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NCT01372644
A Pilot Study of Metabolic Effects of Omentectomy
NCT00565799
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
NCT00696696
Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation
NCT02272400
A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
NCT00468143
Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions
NCT01292096
Extended-release Naltrexone for Alcohol Dependence in Primary Care
NCT00620750
A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction
NCT00571922
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
NCT00483327
Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery
NCT00919412
Preventive IVIG Therapy for Congenital Heart Block
NCT00460928
Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation
NCT00540046
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
NCT00483119
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin
NCT00840450
Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department
NCT00681902
Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers
NCT01320098
A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis
NCT00563212
Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women
NCT00883272
Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients
NCT00583310
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
NCT01083043
Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
NCT00393913
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
NCT00381407
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
NCT00120874
Improving Parental Understanding of Medication Instructions Through a Pictogram-Based Intervention
NCT00537433
Psychiatric and Cognitive Manifestations of Parkinson's Disease
NCT00360633
Transfer of Grasp Control Across Hands After Stroke
NCT00589368
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
NCT00212550
Detecting an Early Response to Donepezil With Measures of Visual Attention
NCT03073876
Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening
NCT00836303
Promoting Early School Readiness in Primary Health Care
NCT00212576
Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors
NCT00528437
Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
NCT00343473
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT00241176
ParentCorps: Promoting Healthy Development in Children From Low Income Communities
NCT01670227
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
NCT00857246
Lap-Band Surgery on Adolescents for Safety and Efficacy
NCT00587301
Family Approach to Managing Asthma in Early Teens
NCT00241852
Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
NCT00391430
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer
NCT00861471
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.